ARTEMIDE-Biliary01_D7025C00001 Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)

Gastrointestinal tumors
Hepatobiliary tumors
Adjuvant Therapy
A global study to assess the efficacy and tolerability of rilvegostomig compared toplacebo in combination with investigator's choice of chemotherapy in participants withBTC after surgical resection with curative intent.
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Global Study of Rilvegostomig in Combination With Chemotherapy as Adjuvant Treatment After Resection of Biliary Tract Cancer With Curative Intent (ARTEMIDE-Biliary01)